XOMA Royalty Stock Quote XOMA - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

26.11

Bid

16.63

Ask

28.23

Volume

11,906

25.96 Day's Range 26.92

13.48 52 Week Range 30.36

Market Cap

305.604M

Previous Close

26.92

Open

26.92

Last Trade

26.11

Last Trade Time

16:20:00

Financial Volume

$ 316,230

VWAP

26.5605

Average Volume (3m)

22,856

Shares Outstanding

11,704,467

Dividend Yield

PE Ratio

-7.48

Earnings Per Share (EPS)

-3.49

Revenue

4.76M

Net Profit

-40.83M

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.xoma.com

Headquarters

Wilmington, Delaware, USA

Founded

XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMA. The last closing price for XOMA Royalty was $26.92. Over the last year, XOMA Royalty shares have traded in a share price range of $ 13.48 to $ 30.36.

XOMA Royalty currently has 11,704,467 shares outstanding. The market capitalization of XOMA Royalty is $315.08 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.48.

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following...

XOMA Royalty to Present at Upcoming Investor Conferences in September

EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at...

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

Cash receipts totaled $22.6 million in 2Q24, inclusive of royalty income and milestones from Day One Pharmaceuticals and Rezolute Expanded the commercial royalty and milestone portfolio with the...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher

EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has received an $8.1 million milestone payment from...

XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ

EMERYVILLE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today that members of its Executive Team will participate in the...

XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities

Earned $9 million milestone upon U.S. Food and Drug Administration’s approval of Day One’s OJEMDA™ (tovorafenib); XOMA is entitled to receive a mid-single digit royalty on OJEMDA™ sales Acquired...

XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%

Organon, a global women’s healthcare company, initiated XACIATO™ commercial activities in the fourth quarter of 2023 XOMA further expands its late-stage portfolio with synthetic royalty and...

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)

XOMA is entitled to a mid-single digit royalty on global OJEMDA™ sales First and only FDA-approved type II RAF inhibitor for patients with relapsed or refractory pLGG harboring a BRAF fusion or...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-2.42	-8.48229933403	28.53	29.9	25.45	32981	27.9697535	CS
4	-3.56	-11.9986518369	29.67	29.9	25.45	23387	28.03696829	CS
12	1.18	4.7332531087	24.93	30.36	22.7	22856	27.56918339	CS
26	1.04	4.14838452333	25.07	30.36	21.27	19576	26.19630572	CS
52	10.47	66.9437340153	15.64	30.36	13.48	23040	22.09853124	CS
156	1.57	6.39771801141	24.54	32.085	13.48	29433	20.7430573	CS
260	7.38	39.4020288308	18.73	46.32	13.48	36121	24.19906745	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
TBIOTelesis Bio Inc	$ 4.75 (104.74%)	2.95M
NCNANuCana PLC	$ 3.70 (21.31%)	2.05M
LSBLakeShore Biopharma Company Ltd	$ 0.89 (15.58%)	2.77k
MUMicron Technology Inc	$ 109.67 (14.51%)	16.36M
ICGIntchains Group Ltd	$ 9.5101 (13.08%)	1.3k
PXDTPixie Dust Technologies Inc	$ 0.9534 (-57.81%)	2.06k
AAGRAfrican Agriculture Holdings Inc	$ 0.0742 (-44.04%)	2.52M
VSMEVS Media Holdings Ltd	$ 1.13 (-25.66%)	664.55k
MDXHMDxHealth SA	$ 2.0987 (-17.37%)	45.21k
PGYPagaya Technologies Ltd	$ 10.50 (-15.66%)	295.34k
MUMicron Technology Inc	$ 109.67 (14.51%)	16.36M
NVDANVIDIA Corporation	$ 124.57 (0.86%)	8.94M
INTCIntel Corporation	$ 23.87 (1.40%)	8.05M
HOLOMicroCloud Hologram Inc	$ 0.2637 (9.42%)	7.5M
VTRSViatris Inc	$ 11.30 (0.27%)	7.41M